Loading...
Vascular Trauma And Dialysis Pipeline Will Transform Long Term Revenue Potential
AN
AnalystHighTarget
Not Invested
Community Contributor
Published
08 Jan 26
Views
331
08 Jan
US$0.71
AnalystHighTarget's Fair Value
US$22.83
96.9% undervalued intrinsic discount1Y
-66.6%7D
-23.3%1Y
-66.6%7D
-23.3%Author's Valuation
US$22.8396.9% undervalued intrinsic discount
AnalystHighTarget Fair Value